Trial Profile
A phase III,randomized, double-blind, placebo-controlled, two-arm parallel, multicenter study evaluating the efficacy and safety of dexmedetomidine in the prevention of postoperative delirium in subjects undergoing surgery for fractured hip with general anesthesia
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 06 Apr 2017
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Delirium
- Focus Therapeutic Use
- Sponsors Hospira
- 14 Nov 2007 Status changed from suspended to discontinued
- 22 Jun 2007 New trial record.